139 related articles for article (PubMed ID: 15319776)
1. Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen.
Kojima R; Kami M; Nannya Y; Kusumi E; Sakai M; Tanaka Y; Kanda Y; Mori S; Chiba S; Miyakoshi S; Tajima K; Hirai H; Taniguchi S; Sakamaki H; Takaue Y
Biol Blood Marrow Transplant; 2004 Sep; 10(9):645-52. PubMed ID: 15319776
[TBL] [Abstract][Full Text] [Related]
2. Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST).
Yamamoto R; Kusumi E; Kami M; Yuji K; Hamaki T; Saito A; Murasgihe N; Hori A; Kim SW; Makimoto A; Ueyama J; Tanosaki R; Miyakoshi S; Mori S; Morinaga S; Heike Y; Taniguchi S; Masuo S; Takaue Y; Mutou Y
Bone Marrow Transplant; 2003 Dec; 32(11):1089-95. PubMed ID: 14625581
[TBL] [Abstract][Full Text] [Related]
3. Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen.
Maruyama D; Fukuda T; Kato R; Yamasaki S; Usui E; Morita-Hoshi Y; Kim SW; Mori S; Heike Y; Makimoto A; Tajima K; Tanosaki R; Tobinai K; Takaue Y
Biol Blood Marrow Transplant; 2007 Aug; 13(8):932-41. PubMed ID: 17640597
[TBL] [Abstract][Full Text] [Related]
4. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
[TBL] [Abstract][Full Text] [Related]
5. Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases.
Miyakoshi S; Kusumi E; Matsumura T; Hori A; Murashige N; Hamaki T; Yuji K; Uchida N; Masuoka K; Wake A; Kanda Y; Kami M; Tanaka Y; Taniguchi S
Biol Blood Marrow Transplant; 2007 Jul; 13(7):771-7. PubMed ID: 17580255
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.
Cordonnier C; Ribaud P; Herbrecht R; Milpied N; Valteau-Couanet D; Morgan C; Wade A;
Clin Infect Dis; 2006 Apr; 42(7):955-63. PubMed ID: 16511759
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.
Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA
Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036
[TBL] [Abstract][Full Text] [Related]
8. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
9. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
Fuji S; Kim SW; Fukuda T; Mori S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Heike Y; Tobinai K; Tanosaki R; Takaue Y
Biol Blood Marrow Transplant; 2008 May; 14(5):510-7. PubMed ID: 18410893
[TBL] [Abstract][Full Text] [Related]
10. Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years.
Kojima R; Kami M; Kanda Y; Kusumi E; Kishi Y; Tanaka Y; Yoshioka S; Morishima S; Fujisawa S; Mori SI; Kasai M; Hatanaka K; Tajima K; Kasai M; Mitani K; Ichinohe T; Hirai H; Taniguchi S; Sakamaki H; Harada M; Takaue Y
Bone Marrow Transplant; 2005 Oct; 36(8):667-74. PubMed ID: 16113674
[TBL] [Abstract][Full Text] [Related]
11. [Outcome of allogeneic stem cell transplantation for hematological disorders in patients older than 50].
Fujimaki K; Takasaki H; Takabayashi M; Yamaji S; Koharazawa H; Kanamori H; Ishigatsubo Y
Gan To Kagaku Ryoho; 2005 Jan; 32(1):47-51. PubMed ID: 15675581
[TBL] [Abstract][Full Text] [Related]
12. Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin.
Nakai K; Kanda Y; Mineishi S; Saito T; Ohnishi M; Niiya H; Chizuka A; Takeuchi T; Matsubara H; Kami M; Makimoto A; Tanosaki R; Kunitoh H; Tobinai K; Takaue Y
Bone Marrow Transplant; 2002 Feb; 29(3):237-41. PubMed ID: 11859396
[TBL] [Abstract][Full Text] [Related]
13. Retrospective multicenter study of allogeneic peripheral blood stem cell transplantation followed by reduced-intensity conditioning or conventional myeloablative regimen.
Kim DH; Sohn SK; Baek JH; Kim JG; Lee JW; Min WS; Kim DW; Choi SJ; Lee JH; Lee KH; Lee MH; Lee JJ; Kim HJ; Kim CC; Lee KB
Acta Haematol; 2005; 113(4):220-7. PubMed ID: 15983427
[TBL] [Abstract][Full Text] [Related]
14. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
[TBL] [Abstract][Full Text] [Related]
15. Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
Pérez-Simón JA; Díez-Campelo M; Martino R; Brunet S; Urbano A; Caballero MD; de León A; Valcárcel D; Carreras E; del Cañizo MC; López-Fidalgo J; Sierra J; San Miguel JF
Br J Haematol; 2005 Aug; 130(3):394-403. PubMed ID: 16042689
[TBL] [Abstract][Full Text] [Related]
16. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
17. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation.
Thursky K; Byrnes G; Grigg A; Szer J; Slavin M
Bone Marrow Transplant; 2004 Jul; 34(2):115-21. PubMed ID: 15156166
[TBL] [Abstract][Full Text] [Related]
19. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
